Pfizer und BioNTech erhalten positive CHMP-Empfehlung für ihren COVID-19-Impfstoff

NEXT STORY
AIM ImmunoTech Inc.’s Drug Ampligen Awarded FDA’s Orphan Drug Designation Status for the Treatment of Pancreatic Cancer
PREV STORY
Novan Engages Catalent to Develop Intranasal Formulation of Berdazimer Sodium for COVID-19 Program
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Pfizer und BioNTech veröffentlichen weitere Daten aus Phase-3-Studie: Bis zu 6 Monate nach zweiter Impfung hohe Wirksamkeit und keine schweren Sicherheitsbedenken des COVID-19-Impfstoffs bestätigt

author_avatar
NASDAQ Market News

Aptose to Present at the Bloom Burton & Co. Healthcare Investor Conference 2018

author_avatar
NASDAQ Market News

Arog Pharmaceuticals Receives FDA Fast Track Designation for Crenolanib in Relapsed or Refractory FLT3-Positive AML

DALLAS, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage ...

author_avatar
NASDAQ Market News